648 related articles for article (PubMed ID: 17497095)
1. Long-term follow-up of patients with pituitary macroadenomas after postoperative radiation therapy: analysis of tumor control and functional outcome.
Langsenlehner T; Stiegler C; Quehenberger F; Feigl GC; Jakse G; Mokry M; Langsenlehner U; Kapp KS; Mayer R
Strahlenther Onkol; 2007 May; 183(5):241-7. PubMed ID: 17497095
[TBL] [Abstract][Full Text] [Related]
2. Fractionated stereotactic conformal radiotherapy for secreting and nonsecreting pituitary adenomas.
Minniti G; Traish D; Ashley S; Gonsalves A; Brada M
Clin Endocrinol (Oxf); 2006 May; 64(5):542-8. PubMed ID: 16649974
[TBL] [Abstract][Full Text] [Related]
3. Integration of surgery with fractionated stereotactic radiotherapy for treatment of nonfunctioning pituitary macroadenomas.
Paek SH; Downes MB; Bednarz G; Keane WM; Werner-Wasik M; Curran WJ; Andrews DW
Int J Radiat Oncol Biol Phys; 2005 Mar; 61(3):795-808. PubMed ID: 15708259
[TBL] [Abstract][Full Text] [Related]
4. External radiotherapy of pituitary adenomas.
Zierhut D; Flentje M; Adolph J; Erdmann J; Raue F; Wannenmacher M
Int J Radiat Oncol Biol Phys; 1995 Sep; 33(2):307-14. PubMed ID: 7673017
[TBL] [Abstract][Full Text] [Related]
5. Stereotactic conformal radiotherapy for pituitary adenomas: technique and preliminary experience.
Jalali R; Brada M; Perks JR; Warrington AP; Traish D; Burchell L; McNair H; Thomas DG; Robinson S; Johnston DG
Clin Endocrinol (Oxf); 2000 Jun; 52(6):695-702. PubMed ID: 10848873
[TBL] [Abstract][Full Text] [Related]
6. Stereotactic conformal radiotherapy in patients with growth hormone-secreting pituitary adenoma.
Milker-Zabel S; Zabel A; Huber P; Schlegel W; Wannenmacher M; Debus J
Int J Radiat Oncol Biol Phys; 2004 Jul; 59(4):1088-96. PubMed ID: 15234043
[TBL] [Abstract][Full Text] [Related]
7. Biochemical remission and recurrence rate of secreting pituitary adenomas after transsphenoidal adenomectomy: long-term endocrinologic follow-up results.
Santoro A; Minniti G; Ruggeri A; Esposito V; Jaffrain-Rea ML; Delfini R
Surg Neurol; 2007 Nov; 68(5):513-8; discussion 518. PubMed ID: 17961741
[TBL] [Abstract][Full Text] [Related]
8. The long-term efficacy of conventional radiotherapy in patients with GH-secreting pituitary adenomas.
Minniti G; Jaffrain-Rea ML; Osti M; Esposito V; Santoro A; Solda F; Gargiulo P; Tamburrano G; Enrici RM
Clin Endocrinol (Oxf); 2005 Feb; 62(2):210-6. PubMed ID: 15670198
[TBL] [Abstract][Full Text] [Related]
9. Long-term visual changes following pituitary irradiation.
Movsas B; Movsas TZ; Steinberg SM; Okunieff P
Int J Radiat Oncol Biol Phys; 1995 Oct; 33(3):599-605. PubMed ID: 7558949
[TBL] [Abstract][Full Text] [Related]
10. [Postoperative radiotherapy in adenomas of the hypophysis].
Waugh E; Baeza MR; Tagle P; Arteaga E
Rev Med Chil; 1992 Feb; 120(2):147-52. PubMed ID: 1340551
[TBL] [Abstract][Full Text] [Related]
11. Influence of radiotherapy on long-term relapse in clinically non-secreting pituitary adenomas. A retrospective study (1970-1988).
Jaffrain-Rea ML; Derome P; Bataini JP; Thomopoulos P; Bertagna X; Luton JP
Eur J Med; 1993; 2(7):398-403. PubMed ID: 8258027
[TBL] [Abstract][Full Text] [Related]
12. Outcome of fractionated stereotactic radiotherapy in patients with pituitary adenomas resistant to conventional treatments: a 5.25-year follow-up study.
Schalin-Jäntti C; Valanne L; Tenhunen M; Setälä K; Paetau A; Sane T; Kouri M
Clin Endocrinol (Oxf); 2010 Jul; 73(1):72-7. PubMed ID: 20039898
[TBL] [Abstract][Full Text] [Related]
13. Long-term outcomes of radiotherapy for pituitary adenomas.
Snead FE; Amdur RJ; Morris CG; Mendenhall WM
Int J Radiat Oncol Biol Phys; 2008 Jul; 71(4):994-8. PubMed ID: 18403133
[TBL] [Abstract][Full Text] [Related]
14. Immediate postoperative radiotherapy in residual nonfunctioning pituitary adenoma: beneficial effect on local control without additional negative impact on pituitary function and life expectancy.
van den Bergh AC; van den Berg G; Schoorl MA; Sluiter WJ; van der Vliet AM; Hoving EW; Szabó BG; Langendijk JA; Wolffenbuttel BH; Dullaart RP
Int J Radiat Oncol Biol Phys; 2007 Mar; 67(3):863-9. PubMed ID: 17197121
[TBL] [Abstract][Full Text] [Related]
15. Stereotactic radiotherapy for the treatment of pituitary adenomas.
Selch MT; Gorgulho A; Lee SP; Mattozo C; Solberg TD; Agazaryan N; Desalles AA
Minim Invasive Neurosurg; 2006 Jun; 49(3):150-5. PubMed ID: 16921455
[TBL] [Abstract][Full Text] [Related]
16. [The diagnosis and therapy of subclinical pituitary adenoma apoplexy].
Li JL; Yu CJ
Zhonghua Wai Ke Za Zhi; 2005 Jul; 43(13):879-81. PubMed ID: 16083609
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and safety of higher dose stereotactic radiosurgery for functional pituitary adenomas: a preliminary report.
Grant RA; Whicker M; Lleva R; Knisely JP; Inzucchi SE; Chiang VL
World Neurosurg; 2014; 82(1-2):195-201. PubMed ID: 23385448
[TBL] [Abstract][Full Text] [Related]
18. Intensity-modulated radiotherapy for pituitary adenomas: the preliminary report of the Cleveland Clinic experience.
Mackley HB; Reddy CA; Lee SY; Harnisch GA; Mayberg MR; Hamrahian AH; Suh JH
Int J Radiat Oncol Biol Phys; 2007 Jan; 67(1):232-9. PubMed ID: 17084541
[TBL] [Abstract][Full Text] [Related]
19. [Analysis of 68 patients with pituitary adenoma treated by radiotherapy].
Hu CS; Ying HM; Shen CY
Ai Zheng; 2002 Oct; 21(10):1154-7. PubMed ID: 12508665
[TBL] [Abstract][Full Text] [Related]
20. Magnetic resonance imaging after transsphenoidal surgery of clinically non-functional pituitary macroadenomas and its impact on detecting residual adenoma.
Kremer P; Forsting M; Ranaei G; Wüster C; Hamer J; Sartor K; Kunze S
Acta Neurochir (Wien); 2002 May; 144(5):433-43. PubMed ID: 12111499
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
